GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » Other Stockholders Equity

Syncom Formulation (India) (NSE:SYNCOMF) Other Stockholders Equity : ₹1,941 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) Other Stockholders Equity?

Syncom Formulation (India)'s Other Stockholders Equity for the quarter that ended in Mar. 2024 was ₹1,941 Mil.

Syncom Formulation (India)'s quarterly Other Stockholders Equity declined from Sep. 2023 (₹1,762 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹1,941 Mil).

Syncom Formulation (India)'s annual Other Stockholders Equity declined from Mar. 2022 (₹613 Mil) to Mar. 2023 (₹583 Mil) but then increased from Mar. 2023 (₹583 Mil) to Mar. 2024 (₹1,941 Mil).


Syncom Formulation (India) Other Stockholders Equity Historical Data

The historical data trend for Syncom Formulation (India)'s Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Other Stockholders Equity Chart

Syncom Formulation (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 544.35 648.44 613.49 582.72 1,941.43

Syncom Formulation (India) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 582.72 - 1,761.71 - 1,941.43

Syncom Formulation (India) Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Syncom Formulation (India) Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines